An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

Active, not recruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2028

Conditions
NAFLDNASH
Interventions
DEVICE

Magnetic Resonance Imaging (MRI)

MRI procedures will include a 20-25 exam with periodic breath holds. The imaging series will be conducted twice to assess repeatability.

DEVICE

Ultrasound (US)

In each ultrasound exam, each participant will be scanned by two sonographers to evaluate inter-operator variability. Each exam will take approximately 60 minutes to complete. The imaging series will be conducted twice to assess repeatability.

Trial Locations (1)

53705

University of Wisconsin, Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT06354491 - An Imaging-based Quantitative Biomarker Assay for NAFLD in Children | Biotech Hunter | Biotech Hunter